Centre National De La Recherche Scientifique

Centre Hospitalier Universitaire De Nice

Université Cote D'azur

Centre National De La Recherche Scientifique-cnrs

Georges Carle

Thierry Balaguer

Nathalie Rochet

Robert Staraj

Philippe Le Thuc

Aliou Diallo

Abdelilah Wakkach

Christophe Trojani

Florian Boukhechba

Claudine Blin-Wakkach

David Momier

Philippe Perrisol

A method for tracking the activity of animals confined in a facility including at least one cage, a plurality of antennae arranged underneath the at least one cage, an RFID reader to which the plurality of antennae are connected, a computer capable of controlling transmission and reception by the RFID reader, and an RFID tag to be fitted to an animal confined in the cage, the method including that the following steps are carried out:—the animal is fitted with the tag,—the RFID reader generates the transmission of an electromagnetic wave at the plurality of antennae,—the RFID reader identifies which antenna(e) has/have received the response transmitted by the tag,—the computer analyses over a given period which antennae have received a signal transmitted by the tag, thus determining the consecutive positions of the animal.

Method, facility and tag for tracking the activity of animals in captivity

The invention relates to a biomaterial containing coagulated blood or coagulated bone marrow aspirate and biphasic calcium phosphate ceramic particles, to a production method thereof and to the use of same for the production of an implant that enables bone tissue regeneration.

Combination of blood and of biphasic calcium phosphate ceramic particles

The invention relates to a biomaterial containing calcium phosphate, in particular hydroxyapatite or a material containing hydroxyapatite, such as biphasic calcium phosphates and calcium phosphate cements, and to the use thereof for the production of an implant or for fitting a prosthesis for the purpose of bone tissue regeneration.

Biomaterials containing calcium phosphate

A composition is adapted for intra-tumoral administration of a subject suffering from cancer, whereby administration of the composition to the subject induces IMC differentiation by neutralizing a factor implicated in a DC differentiation defect.

Composition for treating cancer adapted for intra-tumoral administration and uses thereof

Growing community of inventors

Nice, France

Georges Carle